Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation

Open access
Benson, Micah J., Pino-Lagos, Karina, Rosemblatt, Mario, Noelle, Randolph J. · 2007 · The Journal of Experimental Medicine

Abstract

We demonstrate that all-trans retinoic acid (RA) induces FoxP3+ adaptive T regulatory cells (A-Tregs) to acquire a gut-homing phenotype (α4β7+ CC chemokine receptor 9+) and the capacity to home to the lamina propria of the small intestine. Under conditions that favor the differentiation of A-Tregs (transforming growth factor–β1 and interleukin 2) in vitro, the inclusion of RA induces nearly all activated CD4+ T cells to express FoxP3 and greatly increases the accumulation of these cells. In the absence of RA, A-Treg differentiation is abruptly impaired by proficient antigen presenting cells or through direct co-stimulation. In the presence of RA, A-Treg generation occurs even in the presence of high levels of co-stimulation, with RA attenuating co-stimulation from interfering from FoxP3 induction. The recognition that RA induces gut imprinting, together with our finding that it enhances A-Treg conversion, differentiation, and expansion, indicates that RA production in vivo may drive both the imprinting and A-Treg development in the face of overt inflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20070719

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. RA synergizes with TGF-β1 in the generation of gut-homing A-Tregs in vitro. (A and B) FACS-sorted CD4+Foxp3− cells from the Foxp3/GFP reporter mouse were cultured under activating conditions with IL-2 and TGF-β1 ± 10 nM RA, and surface phenotype and Foxp3/GFP expression was analyzed by flow cytometry after 5 d of culture. (A) Representative staining showing the percentage of Foxp3/GFP expression against CD25, CD62L, α4β7, CCR9, and CD103. (B) Representative FACS plot depicting Foxp3/GFP expression by CD4+ T cells. (C) Quantification of one representative experiment showing the percentage of Foxp3/GFP+ cells among all CD4+ cells, with the selective RA receptor antagonist LE540 (1 μM) included as indicated. Mean ± SEM is shown. (D) Foxp3/GFP expression by CD4+ cells as a function of titrating concentrations of TGF-β1 ± RA. IL-2 concentrations were kept constant, ±RA, with TGF-β1 (20 ng/ml, 10 ng/ml, 5 ng/ml, 1 ng/ml, and 0) titrated. (E) TGF-β–mediated Foxp3/GFP expression as a result of titrating concentrations of RA. Keeping IL-2 and TGF-β1 constant, RA was titrated in serial dilutions (100 nM, 10 nM, 1 nM, 100 pM, 10 pM, 1 pM, and 0). All experiments shown are representative of at least n = 3 independent experiments.
Figure 1. RA synergizes with TGF-β1 in the generation of gut-homing A-Tregs in vitro. (A and B) FACS-sorted CD4+Foxp3− cells from the Foxp3/GFP reporter mouse were cultured under activating conditions with IL-2 and TGF-β1 ± 10 nM RA, and surface phenotype and Foxp3/GFP expression was analyzed by flow cytometry after 5 d of culture. (A) Representative staining showing the percentage of Foxp3/GFP expression against CD25, CD62L, α4β7, CCR9, and CD103. (B) Representative FACS plot depicting Foxp3/GFP expression by CD4+ T cells. (C) Quantification of one representative experiment showing the percentage of Foxp3/GFP+ cells among all CD4+ cells, with the selective RA receptor antagonist LE540 (1 μM) included as indicated. Mean ± SEM is shown. (D) Foxp3/GFP expression by CD4+ cells as a function of titrating concentrations of TGF-β1 ± RA. IL-2 concentrations were kept constant, ±RA, with TGF-β1 (20 ng/ml, 10 ng/ml, 5 ng/ml, 1 ng/ml, and 0) titrated. (E) TGF-β–mediated Foxp3/GFP expression as a result of titrating concentrations of RA. Keeping IL-2 and TGF-β1 constant, RA was titrated in serial dilutions (100 nM, 10 nM, 1 nM, 100 pM, 10 pM, 1 pM, and 0). All experiments shown are representative of at least n = 3 independent experiments.CC BY-NC-SA · PubMed Central
Figure 2. RA–T reg cells are suppressive in vitro and home to the small intestine in vivo. To examine the suppressive capacity of A-Tregs, RA–T reg cells, and nTregs, Ly5.2+Foxp3/GFP+ A-Tregs and RA–T reg cells were generated in vitro and sorted to >99% purity, with Ly5.2+ nTregs freshly isolated ex vivo from a Ly5.2+Foxp3/GFP reporter mouse. These T reg cell subsets were cultured with CFSE-labeled Ly5.1+CD4+ T effector cells at the indicated ratios under activating conditions. Representative CFSE plots of the T effector cells are shown (A), with the percentage of dividing T effector cells quantified (B). (C and D) Representative in vivo competitive homing assay. Naive CD4+Foxp3− cells were sorted from an Ly5.2+Foxp3/GFP reporter mouse and activated for 5 d in the presence of TGF-β1, IL-2, and RA to generate RA–T reg cells expressing Foxp3/GFP. Naive CD4+CD25− cells were sorted from an Ly5.2+ mouse and cultured under the same conditions, minus the RA, to generate A-Tregs lacking the Foxp3/GFP allele. These two cell populations were mixed and injected into recipient mice. (C) Organs were harvested after 18 h and stained for donor Ly5.2+CD4+ T cells, and the ratio of GFP+/− cells within the donor population was analyzed, with a representative mouse shown. Numbers show the percentage of transfered cells that are FoxP3/GFP− and FoxP3/GFP+. (D) The HI (ration of [GFP+]tissue/[GFP−]tissue to [GFP+]input/[GFP−]input) was calculated, with bar graphs showing mean ± SEM of one representative experiment using three recipient mice. Peripheral lymph node (pLN): HI = 0.96 (SEM = 0.13); spleen: HI = 0.96 (SEM = 0.08); blood: HI = 0.56 (SEM = 0.05); lung: HI = 0.39 (SEM = 0.02); mesenteric lymph node (mLN): HI = 1.86 (SEM = 0.1); Peyer's patches (PP): HI = 3.46 (SEM = 0.33); and lamina propria (LP): HI = 12.27 (SEM = 0.77). All experiments are representative of at least two independent experiments. *, P < 0.05; **, P < 0.01; and ***, P < 0.001 compared with HI = 1 (dotted line).
Figure 2. RA–T reg cells are suppressive in vitro and home to the small intestine in vivo. To examine the suppressive capacity of A-Tregs, RA–T reg cells, and nTregs, Ly5.2+Foxp3/GFP+ A-Tregs and RA–T reg cells were generated in vitro and sorted to >99% purity, with Ly5.2+ nTregs freshly isolated ex vivo from a Ly5.2+Foxp3/GFP reporter mouse. These T reg cell subsets were cultured with CFSE-labeled Ly5.1+CD4+ T effector cells at the indicated ratios under activating conditions. Representative CFSE plots of the T effector cells are shown (A), with the percentage of dividing T effector cells quantified (B). (C and D) Representative in vivo competitive homing assay. Naive CD4+Foxp3− cells were sorted from an Ly5.2+Foxp3/GFP reporter mouse and activated for 5 d in the presence of TGF-β1, IL-2, and RA to generate RA–T reg cells expressing Foxp3/GFP. Naive CD4+CD25− cells were sorted from an Ly5.2+ mouse and cultured under the same conditions, minus the RA, to generate A-Tregs lacking the Foxp3/GFP allele. These two cell populations were mixed and injected into recipient mice. (C) Organs were harvested after 18 h and stained for donor Ly5.2+CD4+ T cells, and the ratio of GFP+/− cells within the donor population was analyzed, with a representative mouse shown. Numbers show the percentage of transfered cells that are FoxP3/GFP− and FoxP3/GFP+. (D) The HI (ration of [GFP+]tissue/[GFP−]tissue to [GFP+]input/[GFP−]input) was calculated, with bar graphs showing mean ± SEM of one representative experiment using three recipient mice. Peripheral lymph node (pLN): HI = 0.96 (SEM = 0.13); spleen: HI = 0.96 (SEM = 0.08); blood: HI = 0.56 (SEM = 0.05); lung: HI = 0.39 (SEM = 0.02); mesenteric lymph node (mLN): HI = 1.86 (SEM = 0.1); Peyer's patches (PP): HI = 3.46 (SEM = 0.33); and lamina propria (LP): HI = 12.27 (SEM = 0.77). All experiments are representative of at least two independent experiments. *, P < 0.05; **, P < 0.01; and ***, P < 0.001 compared with HI = 1 (dotted line).CC BY-NC-SA · PubMed Central
Figure 3. DC expression of CD80/86 co-stimulatory molecules prevents Foxp3 induction by T cells, with exogenous RA overcoming this inhibition and allowing T reg cell generation. Sorted CD4+OTII+Foxp3− T cells from the OTII+Foxp3/GFP reporter mouse (100,000 T cells/well) were cultured with either purified WT or CD80/86 knockout CD19+ B cells or CD11c+ DCs (100,000 APCs/well) pulsed with ISQ peptide, or under activating conditions. Media was supplemented with 100 U IL-2, ±20 ng/ml TGF-β1, ±1 nM RA, ±10 μg/ml αCD154 (unless otherwise indicated) for 5 d. (A) WT or CD80/86 knockout splenic B cells or DCs plus T cells were cultured under the depicted culture conditions, and the percentage of CD4+ T cells expressing Foxp3/GFP was measured. (B) Same experimental conditions as in A, except with absolute CD4+ T cells per well counted, with white bars representing CD4+Foxp3− cells and green bars representing CD4+Foxp3+ cells. (C) Freshly harvested B cells (quiescent B cells) or 48-h preactivated B cells with the indicated stimulus were co-cultured with T cells, and the percentage of CD4+ cells expressing Foxp3/GFP was measured after 5 d. (D) CD4+ T cells were activated using 10 μg/ml of plate-bound αCD3 and titrating concentrations of αCD28, with media supplemented with IL-2 and TGF-β1 ±10 nM RA as indicated; Foxp3/GFP expression was plotted as a function of plate-bound αCD28 concentration. Mean ± SEM is depicted in A, B, and D.
Figure 3. DC expression of CD80/86 co-stimulatory molecules prevents Foxp3 induction by T cells, with exogenous RA overcoming this inhibition and allowing T reg cell generation. Sorted CD4+OTII+Foxp3− T cells from the OTII+Foxp3/GFP reporter mouse (100,000 T cells/well) were cultured with either purified WT or CD80/86 knockout CD19+ B cells or CD11c+ DCs (100,000 APCs/well) pulsed with ISQ peptide, or under activating conditions. Media was supplemented with 100 U IL-2, ±20 ng/ml TGF-β1, ±1 nM RA, ±10 μg/ml αCD154 (unless otherwise indicated) for 5 d. (A) WT or CD80/86 knockout splenic B cells or DCs plus T cells were cultured under the depicted culture conditions, and the percentage of CD4+ T cells expressing Foxp3/GFP was measured. (B) Same experimental conditions as in A, except with absolute CD4+ T cells per well counted, with white bars representing CD4+Foxp3− cells and green bars representing CD4+Foxp3+ cells. (C) Freshly harvested B cells (quiescent B cells) or 48-h preactivated B cells with the indicated stimulus were co-cultured with T cells, and the percentage of CD4+ cells expressing Foxp3/GFP was measured after 5 d. (D) CD4+ T cells were activated using 10 μg/ml of plate-bound αCD3 and titrating concentrations of αCD28, with media supplemented with IL-2 and TGF-β1 ±10 nM RA as indicated; Foxp3/GFP expression was plotted as a function of plate-bound αCD28 concentration. Mean ± SEM is depicted in A, B, and D.CC BY-NC-SA · PubMed Central
Figure 4. RA enhances Foxp3 expression without impeding T cell activation and proliferation. Purified CFSE-labeled CD4+CD25− T cells from a WT B6 mouse were cultured with IL-2, TGF-β1, and 1 nM RA, as indicated, under activating conditions for 4 d, after which CD62L and Foxp3 expression was measured. (A) CFSE dye dilution versus CD62L expression is shown, with T cells cultured with IL-2 or IL-2 plus 1 nM RA under different activating conditions. The percentage of T cells within each quadrant is depicted. (B) Histograms depicting CFSE dye dilution profiles of the data shown in A (IL-2, blue; IL-2 with 1 nM RA, red). (C) CFSE dye dilution versus Foxp3 expression is shown with the indicated activating and culture conditions, with the percentage of cells in each quadrant shown. Representative experiments of at least n = 3 mice are shown.
Figure 4. RA enhances Foxp3 expression without impeding T cell activation and proliferation. Purified CFSE-labeled CD4+CD25− T cells from a WT B6 mouse were cultured with IL-2, TGF-β1, and 1 nM RA, as indicated, under activating conditions for 4 d, after which CD62L and Foxp3 expression was measured. (A) CFSE dye dilution versus CD62L expression is shown, with T cells cultured with IL-2 or IL-2 plus 1 nM RA under different activating conditions. The percentage of T cells within each quadrant is depicted. (B) Histograms depicting CFSE dye dilution profiles of the data shown in A (IL-2, blue; IL-2 with 1 nM RA, red). (C) CFSE dye dilution versus Foxp3 expression is shown with the indicated activating and culture conditions, with the percentage of cells in each quadrant shown. Representative experiments of at least n = 3 mice are shown.CC BY-NC-SA · PubMed Central
Figure 5. RA–T reg cells are refractory to reversion in vivo. The ability of RA–T reg cells and A-Tregs to revert in vivo was analyzed by transferring 1.5–2 × 106 FACS-sorted congenically marked OTII+ RA–T reg cells or A-Tregs generated from a Ly5.2+OTII+Foxp3/GFP mice into Ly5.1+ hosts, who were either left untouched or intraperitoneally injected on the same day with either CFA or 1 mg OVA/CFA, as indicated. Donor RA–T reg cells or A-Tregs within the spleen were analyzed for Foxp3 expression on day 5 by staining for CD4+Ly5.2+ cells. RA–T reg cells are red, whereas A-Tregs are black (A). Horizontal lines represent the means. To examine relative donor T cell expansion 5 d after transfer, the percentage of donor OTII+ cells within the recipient splenic CD4+ compartment is shown in a box and whisker plot depicting the median, 25th, and 75th percentiles and range of values (B). Data are pooled from n = 3 independent experiments. ***, P < 0.001.
Figure 5. RA–T reg cells are refractory to reversion in vivo. The ability of RA–T reg cells and A-Tregs to revert in vivo was analyzed by transferring 1.5–2 × 106 FACS-sorted congenically marked OTII+ RA–T reg cells or A-Tregs generated from a Ly5.2+OTII+Foxp3/GFP mice into Ly5.1+ hosts, who were either left untouched or intraperitoneally injected on the same day with either CFA or 1 mg OVA/CFA, as indicated. Donor RA–T reg cells or A-Tregs within the spleen were analyzed for Foxp3 expression on day 5 by staining for CD4+Ly5.2+ cells. RA–T reg cells are red, whereas A-Tregs are black (A). Horizontal lines represent the means. To examine relative donor T cell expansion 5 d after transfer, the percentage of donor OTII+ cells within the recipient splenic CD4+ compartment is shown in a box and whisker plot depicting the median, 25th, and 75th percentiles and range of values (B). Data are pooled from n = 3 independent experiments. ***, P < 0.001.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 950

Metadata

Authors
Benson, M. J., Pino-Lagos, K., Rosemblatt, M., & Noelle, R. J.
Affiliations
  • Dartmouth College (US)
  • 1Department of Microbiology and Immunology, Dartmouth Medical School and Norris Cotton Cancer Center, Lebanon, NH 03756
  • Fundación Ciencia and Vida (CL)
Venue
The Journal of Experimental Medicine
Published
2007-07-09
Volume
204
Issue
8
Pages
1765-1774
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2107631420
Cited by
847
References
28
Citations by year
2026: 13 · 2025: 16 · 2024: 18 · 2023: 25 · 2022: 21 · 2021: 28 · 2020: 23 · 2019: 28 · 2018: 35 · 2017: 33 · 2016: 45 · 2015: 49 · 2014: 53 · 2013: 65 · 2012: 60
FWCI
31.46
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Universidad de Chile (submittedVersion)
Funders
  • National Cancer Institute (CA 123079, R01CA123079)
  • National Institute of Allergy and Infectious Diseases (R01AI048667, AI048667)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Keywords
all-trans retinoic acid, regulatory T cells, Foxp3, gut homing, alpha4beta7 integrin, CCR9, Treg differentiation, costimulation, antigen-presenting cells, lamina propria, CD4+ T cells, inflammation, TGF-β1, interleukin-2
MeSH terms
Animals, Cell Differentiation, Intestine, Small, Mice, Inbred C57BL, Models, Biological, T-Lymphocytes, Tretinoin, CD4-Positive T-Lymphocytes, B7-1 Antigen, Genomic Imprinting, T-Lymphocytes, Regulatory, Mice, B7-2 Antigen, Transforming Growth Factor beta1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. https://app.cochat.ai/papers/10.1084/jem.20070719
The paper
Benson, M. J., Pino-Lagos, K., Rosemblatt, M., & Noelle, R. J. (2007). All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. The Journal of Experimental Medicine. https://doi.org/10.1084/jem.20070719

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.